Neurodiversity
Psychedelic inspires discovery of two new drug candidates for depression
Researchers have found ibogaine-inspired compounds effective in treating depression and addiction in mouse models.
DMT therapy appears effective for depression in phase 2 clinical trial
London-based Small Pharma has released positive top-line results for their phase 2a trial of DMT as an antidepressant.
Deep brain stimulation can be life-altering for OCD sufferers when other treatment options fall short
Deep brain stimulation relies on thin electrodes implanted deep in the brain that deliver electrical currents. Could it treat OCD?
An ancient technique can improve your attention span
Life's modern distractions, such as news and social media, have overwhelmed our evolutionarily designed attention spans.
The Biden administration is preparing for legal psychedelics within two years
The Biden administration’s Department of Health and Human Services has sent a memo supportive of psychedelic therapies. What does that mean for the field?
Flickering screens help kids with reading disabilities
Adding visual white noise to computer screens appears to help children with reading disabilities read and recall words written on them.
New Google tool lets you experience synesthesia
Google’s new online tool lets you experience synesthesia like the abstract artist Vasily Kandinsky, who could hear colors and see sounds.
Is autism a mysterious medical condition or part of the spectrum of human diversity?
Rethinking Autism: Interview with NeuroTribes Author Steve Silberman